Semaglutide has emerged as a promising treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and reducing glucagon https://janicezrjy328956.idblogz.com/36173213/comprehending-semaglutide-a-comprehensive-guide